Tadashi Okimura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tadashi Okimura has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Keiichi Kato
Kato Ladies Clinic, Tokyo, Japan
3 shared publications - Kenji Ezoe
Kato Ladies Clinic, 7-20-3 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan
3 shared publications Akiko Yabuuchi
StemCell Technologies, Vancouver, British Columbia, Canada
2 shared publications- Akiko Yabuuchi
Kato Ladies Clinic Tokyo Japan
2 shared publications Kazuo Uchiyama
Kato Ladies Clinic, 7-20-3 Nishishinjuku, Shinjuku-ku Tokyo 160-0023, Japan
2 shared publications- Satoshi Ueno
Kato Ladies Clinic, 7-20-3 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan
2 shared publications
Latest Publications
- Open Access
- 1 June 2025
- Published by World Scientific Pub Co Pte Ltd in Fertility & Reproduction
- Vol. 07 (02) , 95-102
Pre-Vitrification Artificial Shrinkage Mitigates the Cryo-Injury When Biopsied Blastocysts are Already Re-Expanding
Introduction: Vitrifying blastocysts immediately after trophectoderm biopsy is recommended in clinical settings. However, in some cases, embryologists cannot perform vitrification immediately after biopsy because of other tasks, during which the blastocysts may begin to re-expand. Aims: This study aimed to investigate whether artificial shrinkage (AS) before vitrification affects adhesion capabilities and outgrowth competence of biopsied blastocysts with various re-expansion degrees. Methods: In total, 225 vitrified human blastocysts donated for research by consenting couples were used. Biopsied blastocysts were vitrified at 0–3 hours post-biopsy. The re-expansion degree (%) just before vitrification was calculated using the blastocyst diameter post-biopsy (Db), diameter just before vitrification (Dv), and intra-zona pellucida diameter (Dz) according to the following formula: (Dv - Db)/(Dz - Db) × 100. The blastocysts were categorized according to re-expansion degree as Expansion I, [ ] 0%; Expansion II, 1%–49%; Expansion III, 50%–99%; and Expansion IV, [ ]100%. Some blastocysts were artificially shrunk in hypertonic solution before vitrification. Correlations among outgrowth outcomes, re-expansion degree, and AS were examined. Results: Multivariate linear regression analysis demonstrated that the blastocyst outgrowth area was significantly smaller in the Expansion III group ([ ] = 0.0134). The outgrowth area in the Expansion III group was recovered by AS before vitrification ([ ] = 0.0103) and was comparable to those observed in the Expansion I, II, and IV groups. Conclusions: The outgrowth competence was adversely affected when blastocysts were vitrified during the late re-expansion period; however, this adverse effect was mitigated by pre-vitrification AS. Our findings may contribute to the improvement of day-to-day practices in embryology laboratories.
- 1 June 2025
- Published by World Scientific Pub Co Pte Ltd in Fertility & Reproduction
- Vol. 07 (02) , 95-102
Open AccessPre-Vitrification Artificial Shrinkage Mitigates the Cryo-Injury When Biopsied Blastocysts are Already Re-Expanding
Introduction: Vitrifying blastocysts immediately after trophectoderm biopsy is recommended in clinical settings. However, in some cases, embryologists cannot perform vitrification immediately after biopsy because of other tasks, during which the blastocysts may begin to re-expand. Aims: This study aimed to investigate whether artificial shrinkage (AS) before vitrification affects adhesion capabilities and outgrowth competence of biopsied blastocysts with various re-expansion degrees. Methods: In total, 225 vitrified human blastocysts donated for research by consenting couples were used. Biopsied blastocysts were vitrified at 0–3 hours post-biopsy. The re-expansion degree (%) just before vitrification was calculated using the blastocyst diameter post-biopsy (Db), diameter just before vitrification (Dv), and intra-zona pellucida diameter (Dz) according to the following formula: (Dv - Db)/(Dz - Db) × 100. The blastocysts were categorized according to re-expansion degree as Expansion I, [ ] 0%; Expansion II, 1%–49%; Expansion III, 50%–99%; and Expansion IV, [ ]100%. Some blastocysts were artificially shrunk in hypertonic solution before vitrification. Correlations among outgrowth outcomes, re-expansion degree, and AS were examined. Results: Multivariate linear regression analysis demonstrated that the blastocyst outgrowth area was significantly smaller in the Expansion III group ([ ] = 0.0134). The outgrowth area in the Expansion III group was recovered by AS before vitrification ([ ] = 0.0103) and was comparable to those observed in the Expansion I, II, and IV groups. Conclusions: The outgrowth competence was adversely affected when blastocysts were vitrified during the late re-expansion period; however, this adverse effect was mitigated by pre-vitrification AS. Our findings may contribute to the improvement of day-to-day practices in embryology laboratories.
- 16 May 2025
- Published by SAGE Publications in Journal of Adolescent and Young Adult Oncology
- Vol. 15 (1) , 47-57
National Survey on the Status of Embryo Freezing for Fertility Preservation in Japan
Purpose: No studies regarding embryo freezing as a technique for preserving fertility among patients with cancer have been conducted in Japan. Hence, we surveyed embryologists working at fertility preservation facilities to investigate the current status of embryo freezing for fertility preservation in patients with cancer in Japan. Methods: Embryologists from 622 institutions registered for in vitro fertilization and embryo transfer with the Japan Society of Obstetrics and Gynecology were surveyed online about their embryo freezing practices. Results: The survey revealed that 352 institutions perform embryo freezing for general assisted reproduction, while only 178 (50.6%) do so for fertility preservation. About 23.0% use different criteria or personnel for cryopreservation based on purpose, 15.2% freeze pronuclear stage embryos, 84.3% freeze cleavage stage embryos, and 92.7% freeze blastocyst stage embryos. All institutions use vitrification, and over 90% follow the manufacturer’s protocol for freezing and thawing. Conclusions: Fertility preservation through embryo freezing is not widely used in Japan, and there is inadequate data on the therapy’s current status and results for patients with cancer. Further research is necessary to provide patients with cancer with the opportunity to preserve their fertility without major concerns and ultimately enhance their quality of life after treatment.
- 16 May 2025
- Published by SAGE Publications in Journal of Adolescent and Young Adult Oncology
- Vol. 15 (1) , 47-57
National Survey on the Status of Embryo Freezing for Fertility Preservation in Japan
Purpose: No studies regarding embryo freezing as a technique for preserving fertility among patients with cancer have been conducted in Japan. Hence, we surveyed embryologists working at fertility preservation facilities to investigate the current status of embryo freezing for fertility preservation in patients with cancer in Japan. Methods: Embryologists from 622 institutions registered for in vitro fertilization and embryo transfer with the Japan Society of Obstetrics and Gynecology were surveyed online about their embryo freezing practices. Results: The survey revealed that 352 institutions perform embryo freezing for general assisted reproduction, while only 178 (50.6%) do so for fertility preservation. About 23.0% use different criteria or personnel for cryopreservation based on purpose, 15.2% freeze pronuclear stage embryos, 84.3% freeze cleavage stage embryos, and 92.7% freeze blastocyst stage embryos. All institutions use vitrification, and over 90% follow the manufacturer’s protocol for freezing and thawing. Conclusions: Fertility preservation through embryo freezing is not widely used in Japan, and there is inadequate data on the therapy’s current status and results for patients with cancer. Further research is necessary to provide patients with cancer with the opportunity to preserve their fertility without major concerns and ultimately enhance their quality of life after treatment.
- 1 July 2021
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 36 (Supplement)
O-220 An annotation-free embryo scoring system (iDAScore®) based on deep learning shows high performance for pregnancy prediction after single-vitrified blastocyst transfer
How is the performance of an automated embryo scoring system for pregnancy prediction after single-vitrified blastocyst transfer (SVBT) compared to other, annotation-dependent blastocyst grading systems? Automatic embryo ranking by iDAScore shows a higher or equal performance, with regards to pregnancy prediction after SVBT, compared to manual, annotation-dependent grading systems. Blastocyst viability can be assessed by blastocyst morphology grades and/or morphokinetic parameters. However, morphological and morphokinetic embryo assessment is prone to both inter- and intra-observer variation. Recently, embryo ranking models have been developed based on artificial intelligence (AI) and deep learning. Such models rank embryos according to their potential for pregnancy only based on images and do not require any user-dependent annotation. So far, no study has independently assessed the performance of AI models compared to other embryo scoring models, including traditional morphological grading. A total of 3,014 SVBT cycles were retrospectively analysed. Embryos were stratified according to SART age groups. The quality and scoring of embryos were assessed by iDAScore v1.0 (iDAS, Vitrolife, Sweden), KIDScoreTM D5 v3 (KS; Vitrolife), and Gardner criteria. The performance of the pregnancy prediction for each embryo scoring model was compared using the area under curve (AUC) of the receiver operating characteristic curve for each maternal age group. Embryos were cultured in the EmbryoScope+ and EmbryoScopeFlex (Vitrolife). iDAS was automatically calculated using the iDAScore model running on the EmbryoViewer (Vitrolife). KS was calculated in EmbryoViewer after annotation of the required parameters. ICM and TE were annotated according to the Gardner criteria. The degree of expansion in all blastocysts was Grade 4 due to our freezing policy. Furthermore, Gardner’s scores were stratified into four grades (Excellent: AA, Good: AB BA, Fair: BB, Poor: others). The AUCs of the < 35 years age group (n = 389) for pregnancy prediction were 0.72 for iDAS, 0.66 for KS and 0.64 for Gardner criteria. The AUC of iDAS was significantly higher (P < 0.05) compared to the other two models. For the 35–37 years age group (n = 514) the AUCs were 0.68, 0.68, and 0.65 for iDAS, KS and Gardner, respectively, and were not significantly different. The AUCs of the 38–40 years age group (n = 796) were 0.67 for iDAS, 0.65 for KS and 0.64 for Gardner criteria and where was not significantly different. The AUCs of the 41–42 years age group (n = 636) were 0.66, 0.66, and 0.63 for iDAS, KS and Gardner, respectively, and there was no significant difference among the pregnancy prediction models. For the > 42 years age group (n = 389) AUCs were 0.76 for iDAS, 0.75 for KS and 0.75 for Gardner criteria and not significantly different. Thus, for all age groups, iDAS was either highest or equal to the highest AUC, although a significant difference was only observed for the youngest age group. In this study, SVBT was performed after minimal stimulation and natural cycle in vitro fertilisation (IVF). Therefore, we had only few cycles with elective blastocyst transfer. However, there was also no bias in selecting the embryos for SVBT. Our results showed that objective embryo assessment by a completely automatic and annotation-free model, iDAScore, does perform as good or even better than more traditional embryo assessment or an annotation-dependent ranking tool. iDAS could be an optimal pregnancy prediction model after SVBT, especially in young and advanced age patients. not applicable
- 1 July 2021
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 36 (Supplement)
O-220 An annotation-free embryo scoring system (iDAScore®) based on deep learning shows high performance for pregnancy prediction after single-vitrified blastocyst transfer
How is the performance of an automated embryo scoring system for pregnancy prediction after single-vitrified blastocyst transfer (SVBT) compared to other, annotation-dependent blastocyst grading systems? Automatic embryo ranking by iDAScore shows a higher or equal performance, with regards to pregnancy prediction after SVBT, compared to manual, annotation-dependent grading systems. Blastocyst viability can be assessed by blastocyst morphology grades and/or morphokinetic parameters. However, morphological and morphokinetic embryo assessment is prone to both inter- and intra-observer variation. Recently, embryo ranking models have been developed based on artificial intelligence (AI) and deep learning. Such models rank embryos according to their potential for pregnancy only based on images and do not require any user-dependent annotation. So far, no study has independently assessed the performance of AI models compared to other embryo scoring models, including traditional morphological grading. A total of 3,014 SVBT cycles were retrospectively analysed. Embryos were stratified according to SART age groups. The quality and scoring of embryos were assessed by iDAScore v1.0 (iDAS, Vitrolife, Sweden), KIDScoreTM D5 v3 (KS; Vitrolife), and Gardner criteria. The performance of the pregnancy prediction for each embryo scoring model was compared using the area under curve (AUC) of the receiver operating characteristic curve for each maternal age group. Embryos were cultured in the EmbryoScope+ and EmbryoScopeFlex (Vitrolife). iDAS was automatically calculated using the iDAScore model running on the EmbryoViewer (Vitrolife). KS was calculated in EmbryoViewer after annotation of the required parameters. ICM and TE were annotated according to the Gardner criteria. The degree of expansion in all blastocysts was Grade 4 due to our freezing policy. Furthermore, Gardner’s scores were stratified into four grades (Excellent: AA, Good: AB BA, Fair: BB, Poor: others). The AUCs of the < 35 years age group (n = 389) for pregnancy prediction were 0.72 for iDAS, 0.66 for KS and 0.64 for Gardner criteria. The AUC of iDAS was significantly higher (P < 0.05) compared to the other two models. For the 35–37 years age group (n = 514) the AUCs were 0.68, 0.68, and 0.65 for iDAS, KS and Gardner, respectively, and were not significantly different. The AUCs of the 38–40 years age group (n = 796) were 0.67 for iDAS, 0.65 for KS and 0.64 for Gardner criteria and where was not significantly different. The AUCs of the 41–42 years age group (n = 636) were 0.66, 0.66, and 0.63 for iDAS, KS and Gardner, respectively, and there was no significant difference among the pregnancy prediction models. For the > 42 years age group (n = 389) AUCs were 0.76 for iDAS, 0.75 for KS and 0.75 for Gardner criteria and not significantly different. Thus, for all age groups, iDAS was either highest or equal to the highest AUC, although a significant difference was only observed for the youngest age group. In this study, SVBT was performed after minimal stimulation and natural cycle in vitro fertilisation (IVF). Therefore, we had only few cycles with elective blastocyst transfer. However, there was also no bias in selecting the embryos for SVBT. Our results showed that objective embryo assessment by a completely automatic and annotation-free model, iDAScore, does perform as good or even better than more traditional embryo assessment or an annotation-dependent ranking tool. iDAS could be an optimal pregnancy prediction model after SVBT, especially in young and advanced age patients. not applicable
- 1 August 2020
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 41 (2) , 191-202
Cytoplasmic halo characteristics during fertilization and their implications for human preimplantation embryo development and pregnancy outcome
- 1 August 2020
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 41 (2) , 191-202
Cytoplasmic halo characteristics during fertilization and their implications for human preimplantation embryo development and pregnancy outcome
- 1 June 2018
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 36 (6) , 614-619
Cryostorage duration does not affect pregnancy and neonatal outcomes: a retrospective single-centre cohort study of vitrified–warmed blastocysts
- 1 June 2018
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 36 (6) , 614-619
Cryostorage duration does not affect pregnancy and neonatal outcomes: a retrospective single-centre cohort study of vitrified–warmed blastocysts